General Information of Drug Transporter (DT)
DT ID DTD0166 Transporter Info
Gene Name SLC24A5
Transporter Name Sodium/potassium/calcium exchanger 5
Gene ID
283652
UniProt ID
Q71RS6
Epigenetic Regulations of This DT (EGR)

Methylation

  Bladder cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

TSS1500 (cg09456905)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.93E+00 Statistic Test p-value: 2.58E-08; Z-score: -1.16E+01

Methylation in Case

3.60E-01 (Median) Methylation in Control 6.94E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

TSS1500 (cg24125468)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.31E+00 Statistic Test p-value: 5.24E-08; Z-score: -6.95E+00

Methylation in Case

2.99E-01 (Median) Methylation in Control 6.89E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

TSS200 (cg19409156)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 5.29E-09; Z-score: -1.18E+01

Methylation in Case

6.60E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

TSS200 (cg01325409)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.33E+00 Statistic Test p-value: 5.61E-08; Z-score: -6.85E+00

Methylation in Case

2.72E-01 (Median) Methylation in Control 6.34E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

TSS200 (cg09625274)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 9.37E-08; Z-score: -7.30E+00

Methylation in Case

5.90E-01 (Median) Methylation in Control 7.85E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

1stExon (cg04643655)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.15E+00 Statistic Test p-value: 1.72E-05; Z-score: -8.56E+00

Methylation in Case

2.25E-01 (Median) Methylation in Control 4.84E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

Body (cg08411738)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 6.97E-05; Z-score: -8.91E+00

Methylation in Case

7.91E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

Body (cg13223777)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 1.13E-04; Z-score: -1.62E+01

Methylation in Case

7.07E-01 (Median) Methylation in Control 8.92E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC24A5 in bladder cancer [ 1 ]

Location

Body (cg18585464)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.17E-04; Z-score: -3.26E+00

Methylation in Case

8.70E-01 (Median) Methylation in Control 9.22E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

TSS1500 (cg24125468)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 7.84E-05; Z-score: -1.13E+00

Methylation in Case

6.82E-01 (Median) Methylation in Control 7.47E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

TSS1500 (cg09456905)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 2.73E-02; Z-score: -4.19E-01

Methylation in Case

5.73E-01 (Median) Methylation in Control 6.25E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

TSS200 (cg01325409)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.01E-07; Z-score: -1.55E+00

Methylation in Case

5.16E-01 (Median) Methylation in Control 6.01E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

TSS200 (cg09625274)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 9.65E-04; Z-score: -8.21E-01

Methylation in Case

7.26E-01 (Median) Methylation in Control 7.70E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

TSS200 (cg19409156)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 4.47E-03; Z-score: -5.44E-01

Methylation in Case

8.28E-01 (Median) Methylation in Control 8.53E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

1stExon (cg04643655)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 3.88E-03; Z-score: -1.09E+00

Methylation in Case

4.05E-01 (Median) Methylation in Control 5.03E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC24A5 in breast cancer [ 2 ]

Location

Body (cg13223777)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 3.97E-03; Z-score: -8.99E-01

Methylation in Case

8.45E-01 (Median) Methylation in Control 8.79E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

TSS1500 (cg09456905)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 3.07E-10; Z-score: -2.20E+00

Methylation in Case

6.41E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

TSS1500 (cg24125468)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 7.59E-10; Z-score: -3.23E+00

Methylation in Case

8.31E-01 (Median) Methylation in Control 9.16E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

TSS200 (cg01325409)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 6.86E-17; Z-score: -5.70E+00

Methylation in Case

5.94E-01 (Median) Methylation in Control 7.98E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

TSS200 (cg19409156)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.62E-04; Z-score: -1.93E+00

Methylation in Case

9.20E-01 (Median) Methylation in Control 9.36E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

TSS200 (cg09625274)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.55E-04; Z-score: -1.54E+00

Methylation in Case

9.08E-01 (Median) Methylation in Control 9.23E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

1stExon (cg04643655)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 1.55E-12; Z-score: -2.84E+00

Methylation in Case

5.52E-01 (Median) Methylation in Control 6.71E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

Body (cg13223777)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 9.89E-05; Z-score: -8.90E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 9.38E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

Body (cg18242760)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.86E-03; Z-score: -1.59E+00

Methylation in Case

9.39E-01 (Median) Methylation in Control 9.49E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

Body (cg08411738)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.42E-02; Z-score: -6.29E-01

Methylation in Case

9.15E-01 (Median) Methylation in Control 9.31E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC24A5 in colorectal cancer [ 3 ]

Location

Body (cg18585464)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 3.90E-02; Z-score: -2.53E-01

Methylation in Case

9.42E-01 (Median) Methylation in Control 9.46E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in hepatocellular carcinoma [ 4 ]

Location

TSS1500 (cg04344565)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.54E+00 Statistic Test p-value: 3.17E-16; Z-score: 4.64E+00

Methylation in Case

3.16E-01 (Median) Methylation in Control 6.95E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in lung adenocarcinoma [ 5 ]

Location

TSS1500 (cg09456905)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 7.32E-03; Z-score: 1.60E+00

Methylation in Case

6.80E-01 (Median) Methylation in Control 6.21E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in panic disorder [ 6 ]

Location

TSS1500 (cg24125468)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.26E+00 Statistic Test p-value: 6.07E-03; Z-score: 7.32E-01

Methylation in Case

1.35E+00 (Median) Methylation in Control 1.07E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in panic disorder [ 6 ]

Location

TSS1500 (cg09456905)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -8.35E-01 Statistic Test p-value: 4.86E-02; Z-score: -2.78E-01

Methylation in Case

-5.65E-01 (Median) Methylation in Control -4.71E-01 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in panic disorder [ 6 ]

Location

Body (cg18242760)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.85E-05; Z-score: -5.20E-01

Methylation in Case

2.14E+00 (Median) Methylation in Control 2.34E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg04237663)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.21E+00 Statistic Test p-value: 2.11E-28; Z-score: 6.95E+00

Methylation in Case

2.29E-01 (Median) Methylation in Control 7.13E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg00068153)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 4.25E-07; Z-score: -2.63E-01

Methylation in Case

8.67E-01 (Median) Methylation in Control 8.71E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg19062099)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 5.64E-05; Z-score: -1.10E+00

Methylation in Case

4.98E-01 (Median) Methylation in Control 5.70E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg00031491)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 6.67E-04; Z-score: 1.12E+00

Methylation in Case

8.49E-01 (Median) Methylation in Control 7.79E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg19117698)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 6.77E-04; Z-score: 8.50E-01

Methylation in Case

7.52E-01 (Median) Methylation in Control 7.25E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg03426615)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 8.08E-04; Z-score: -5.42E-01

Methylation in Case

8.50E-01 (Median) Methylation in Control 8.63E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC24A5 in pancretic ductal adenocarcinoma [ 7 ]

Location

Body (cg09357268)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.07E-02; Z-score: 6.05E-01

Methylation in Case

8.03E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC24A5 in papillary thyroid cancer [ 8 ]

Location

TSS200 (cg19409156)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 9.12E-03; Z-score: 5.94E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 9.13E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC24A5 in papillary thyroid cancer [ 8 ]

Location

Body (cg13223777)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 2.41E-03; Z-score: -8.67E-01

Methylation in Case

9.24E-01 (Median) Methylation in Control 9.35E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC24A5 in papillary thyroid cancer [ 8 ]

Location

Body (cg18585464)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.08E-02; Z-score: -4.52E-01

Methylation in Case

9.36E-01 (Median) Methylation in Control 9.44E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate/significant hypermethylation of SLC24A5 in liver cancer than that in healthy individual/adjacent tissue

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.014021521; Fold-change: -0.28568804; Z-score: -0.919731226

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 1.10E-15; Fold-change: -0.324515793; Z-score: -5.897492375
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Medulloblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC24A5 in medulloblastoma than that in healthy individual

Studied Phenotype

Medulloblastoma [ICD-11:2A00.10]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 8.53E-12; Fold-change: -0.209002525; Z-score: -0.996259881
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC24A5 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.78E-13; Fold-change: -0.200803011; Z-score: -1.875085476
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC24A5 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.02E-13; Fold-change: -0.37617859; Z-score: -3.292267046
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC24A5 in melanocytoma than that in healthy individual

Studied Phenotype

Melanocytoma [ICD-11:2F36.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.56E-20; Fold-change: -0.604165624; Z-score: -8.515650337
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC24A5 in melanoma than that in healthy individual

Studied Phenotype

Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 6.98E-07; Fold-change: -0.412492001; Z-score: -3.400358984
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Pancreatic cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC24A5 in pancreatic adenocarcinoma than that in healthy individual

Studied Phenotype

Pancreatic cancer [ICD-11:2C10]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.016452696; Fold-change: -0.376039048; Z-score: -1.813626259
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
References
1 DNA Methylation Dynamics in Urological Tumors.
2 Genome-wide Scan for Methylation Profiles in Breast Cancer
3 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
4 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
5 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
6 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
7 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.